Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide and Tretinoin in Newly Diagnosed Acute Promyelocytic Leukemia
NCT02339740Phase 3Active, not recruiting
- Sponsor
- Children's Oncology Group
- Start
- Jul 2015
- Primary completion
- Oct 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 6
01
Overview
A Phase 3 trial of arsenic trioxide, tretinoin in acute promyelocytic leukemia (APL), sponsored by Children's Oncology Group. Started Jul 2015; status: active, not recruiting.
02
Drugs
arsenic trioxidetretinoin
03
Conditions
acute promyelocytic leukemia (APL)
Beyond the preview
Go deeper on NCT02339740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02339740.